HOME >> BIOLOGY >> NEWS
16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

The 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics brings 2,000 international cancer experts together to present new data on leading-edge basic, translational and early clinical research.

News briefing:

12.30 hrs CET Wednesday 29 September:

Speakers and topics

    * Dr Monika Hegi: Trial identifies which brain cancer patients benefit from temozolomide: genetic predictive test can be carried out in any laboratory and means temozolomide can now become a targeted treatment.

    * Dr Ardeshir Ghavamzadeh: Trial results indicate arsenic should now be considered first-line treatment for one type of leukaemia

    *Dr Kim Chi: Successful results of Phase I trial of the first second generation antisense cancer drug - phase II getting under way

    * Dr Grant McArthur: Award winning researcher reveals potential new role for Glivec in a soft tissue cancer

Chairman: Professor Jaap Verweij (EORTC chairman of conference scientific committee) together with scientific committee co-chairmen Dr Janet Dancey (NCI) and Dr Eric K Rowinsky (AACR)

NB: any reports involving the topics outlined above are embargoed until the time and date of the news briefings.

Journalists wishing to dial in to the news briefing should contact Margaret Willson by Friday 25 September.

More information:

Margaret Willson
Conference Press Officer

Tel: 44-153-677-2181 (office)
44-797-385-3347 (mobile)
Email: m.willson@mwcommunications.org.uk

Conference media centre:
From 16.00 hrs CET Monday 27 September to 17.00 hrs CET Friday 1 October
Tel: 41-22-761-2205
Fax: 41-22-761-2211


'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-015-367-72181
European Organisation for Research and Treatment of Cancer
22-Sep-2004


Page: 1

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. Health of worlds sea lions the focus of Wakefield Symposium
4. Chemical signals health of brain cells Symposium
5. Final Alert: 16th EORTC NCI AACR Symposium
6. 16th EORTC NCI AACR Symposium
7. Symposium to tackle questions of genetic engineering and biodiversity
8. Fostering Diversity in the Sciences Symposium
9. Annual Chemical Biology Symposium at Yale May 14, 2004
10. Symposium relates long-term ecological research to ecosystem management
11. Symposium examines the growing influence of aerosols on climate

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2020)... ... March 02, 2020 , ... Rigaku ... Conference on Analytical Chemistry and Applied Spectroscopy ( Pittcon 2020 ), being held ... world’s leading annual conference and exposition on laboratory science, attracting attendees from industry, ...
(Date:2/28/2020)... Kan. (PRWEB) , ... February ... ... proudly announces that its patent-pending Rebound PRP™ and Rebound PRF® devices are ... university-validated a new generation of regenerative medical devices, that will provide the ...
(Date:2/28/2020)... ... ... Regen Suppliers is now offering the top FDA Cleared threads available on ... not only one of the only FDA Cleared options available, there are fifteen different ... popularity, as they represent an excellent nonoperative method of reducing wrinkles and helping individuals ...
Breaking Biology News(10 mins):
(Date:4/1/2020)... ... March 31, 2020 , ... ... a method using its revolutionary NEXTGENPCR endpoint thermocycler and consumables that decreases ... volumes, increased samples per run, and standard, affordable laboratory equipment, a qualitative ...
(Date:3/19/2020)... Md. (PRWEB) , ... March ... ... a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company ... cell therapies for ovarian cancer and other solid tumor indications. The collaboration ...
(Date:3/10/2020)... ... March 10, 2020 , ... ... cold chain biopharmaceutical engineering firm, is pleased to announce the addition of ... combination medical device qualification and validation in the biopharmaceutical cold chain. He ...
(Date:3/3/2020)... ... 2020 , ... Ideal Implant Incorporated Founder and CEO, Robert ... the IMCAS Innovation Shark Tank 2020 in Paris, France in January. The international ... science industries that promise to revolutionize medical practices in their fields. , ...
Breaking Biology Technology:
Cached News: